Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?

We have studied the effects of add-on spironolactone treatment (100 mg/day) in 11 patients with idiopathic membranous nephropathy (IMN) and >3 gm proteinuria/day despite angiotensin converting enzyme (ACE) inhibitor therapy titrated to a systolic/diastolic blood pressure <120/80 mmHg. Blood pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cravedi, Paolo, Brusegan, Varusca, Ruggenenti, Piero, Campbell, Ruth, Remuzzi, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991017/
https://www.ncbi.nlm.nih.gov/pubmed/27713239
http://dx.doi.org/10.3390/ph3010001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991017/
https://www.ncbi.nlm.nih.gov/pubmed/27713239
http://dx.doi.org/10.3390/ph3010001

Ejemplares similares